XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Offering
Employee Stock
Private Placement
Equity Award Plan
Common Stock
Common Stock
At The Market Offering
Common Stock
Employee Stock
Common Stock
Private Placement
Common Stock
Equity Award Plan
Additional Paid-In Capital
Additional Paid-In Capital
At The Market Offering
Additional Paid-In Capital
Employee Stock
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Equity Award Plan
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022           36,956,345                      
Beginning balance at Dec. 31, 2022 $ 142,037         $ 4         $ 535,074         $ (392,824) $ (217)
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)                   197,703              
Issuance of common stock in connection with equity award plans / employee stock purchase plan         $ 1,390                   $ 1,390    
Issuance of common stock in at-the-market offerings, net of issuance costs / common stock in private placement, net of issuance costs (in shares)             658,206                    
Issuance of common stock in at-the-market offerings, net of issuance costs / common stock in private placement, net of issuance costs   $ 14,480                   $ 14,480          
Issuance of common stock in connection with achievement of Contingent Milestone (in shares)           199,993                      
Issuance of common stock in connection with achievement of Contingent Milestone 4,292                   4,292            
Stock-based compensation 8,728                   8,728            
Net loss (30,130)                             (30,130)  
Other comprehensive (loss) income 353                               353
Ending balance (in shares) at Mar. 31, 2023           38,012,247                      
Ending balance at Mar. 31, 2023 141,150         $ 4         563,964         (422,954) 136
Beginning balance (in shares) at Dec. 31, 2022           36,956,345                      
Beginning balance at Dec. 31, 2022 142,037         $ 4         535,074         (392,824) (217)
Issuance of common stock in connection with achievement of Contingent Milestone 5,188                                
Net loss (127,756)                                
Ending balance (in shares) at Sep. 30, 2023           46,595,745                      
Ending balance at Sep. 30, 2023 269,081         $ 5         791,114         (520,580) (1,458)
Beginning balance (in shares) at Mar. 31, 2023           38,012,247                      
Beginning balance at Mar. 31, 2023 141,150         $ 4         563,964         (422,954) 136
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)               76,481   101,699              
Issuance of common stock in connection with equity award plans / employee stock purchase plan     $ 1,294   803               $ 1,294   803    
Issuance of common stock in connection with settlement of Indemnification Holdback liability (in shares)           31,631                      
Issuance of common stock in connection with settlement of Indemnification Holdback liability 896                   896            
Stock-based compensation 8,565                   8,565            
Net loss (74,038)                             (74,038)  
Other comprehensive (loss) income (60)                               (60)
Ending balance (in shares) at Jun. 30, 2023           38,222,058                      
Ending balance at Jun. 30, 2023 78,610         $ 4         575,522         (496,992) 76
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)                   373,687              
Issuance of common stock in connection with equity award plans / employee stock purchase plan         4,766                   4,766    
Issuance of common stock in at-the-market offerings, net of issuance costs / common stock in private placement, net of issuance costs (in shares)                 8,000,000                
Issuance of common stock in at-the-market offerings, net of issuance costs / common stock in private placement, net of issuance costs       $ 202,239         $ 1         $ 202,238      
Stock-based compensation 8,588                   8,588            
Net loss (23,588)                             (23,588)  
Other comprehensive (loss) income (1,534)                               (1,534)
Ending balance (in shares) at Sep. 30, 2023           46,595,745                      
Ending balance at Sep. 30, 2023 269,081         $ 5         791,114         (520,580) (1,458)
Beginning balance (in shares) at Dec. 31, 2023           46,723,143                      
Beginning balance at Dec. 31, 2023 248,670         $ 5         803,260         (556,239) 1,644
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)                   337,963              
Issuance of common stock in connection with equity award plans / employee stock purchase plan         1,205                   1,205    
Stock-based compensation 11,664                   11,664            
Net loss (25,279)                             (25,279)  
Other comprehensive (loss) income (1,657)                               (1,657)
Ending balance (in shares) at Mar. 31, 2024           47,061,106                      
Ending balance at Mar. 31, 2024 234,603         $ 5         816,129         (581,518) (13)
Beginning balance (in shares) at Dec. 31, 2023           46,723,143                      
Beginning balance at Dec. 31, 2023 248,670         $ 5         803,260         (556,239) 1,644
Issuance of common stock in connection with achievement of Contingent Milestone 0                                
Net loss (64,152)                                
Ending balance (in shares) at Sep. 30, 2024           47,968,121                      
Ending balance at Sep. 30, 2024 232,024         $ 5         851,490         (620,391) 920
Beginning balance (in shares) at Mar. 31, 2024           47,061,106                      
Beginning balance at Mar. 31, 2024 234,603         $ 5         816,129         (581,518) (13)
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)               68,089   442,652              
Issuance of common stock in connection with equity award plans / employee stock purchase plan     $ 1,433   5,858               $ 1,433   5,858    
Stock-based compensation 12,196                   12,196            
Net loss (24,638)                             (24,638)  
Other comprehensive (loss) income (464)                               (464)
Ending balance (in shares) at Jun. 30, 2024           47,571,847                      
Ending balance at Jun. 30, 2024 228,988         $ 5         835,616         (606,156) (477)
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)                   396,274              
Issuance of common stock in connection with equity award plans / employee stock purchase plan         $ 3,863                   $ 3,863    
Stock-based compensation 12,011                   12,011            
Net loss (14,235)                             (14,235)  
Other comprehensive (loss) income 1,397                               1,397
Ending balance (in shares) at Sep. 30, 2024           47,968,121                      
Ending balance at Sep. 30, 2024 $ 232,024         $ 5         $ 851,490         $ (620,391) $ 920